Development and validation of Risk Equations for Complications Of type 2 Diabetes (RECODe) using individual participant data from randomised trials
The Lancet Diabetes & Endocrinology Sep 30, 2017
Basu S, et al. - In view of substantial mis-estimation of risks of diabetes complications using existing equations, researchers developed updated Risk Equations for Complications Of type 2 Diabetes (RECODe). They recognized their equations as more efficacious regarding discrimination and calibration than the UK Prospective Diabetes Study Outcomes Model 2 (for microvascular and cardiovascular outcomes, C-statistics 0·54Â0·62, slopes 0·06Â1·12) and the American College of Cardiology/American Heart Association Pooled Cohort Equations (for fatal or non-fatal myocardial infarction or stroke, C-statistics 0·61Â0·66, slopes 0·30Â0·39). Thereby suggesting the utility of RECODe in improving estimation of risk of complications for patients with type 2 diabetes.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries